Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$410,082
+$6,314 QoQ
Shares Held
83,181
+11.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 220 holders
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Marex Group plc holds $79,745,220 across 11 Drug Manufacturers - Specialty & Generic names. BHC ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
973,771 | $33,760,640 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
3,250,000 | $31,947,500 | |
| 3 | GLAS |
Glass House Brands Inc.
|
750,000 | $9,750,000 | |
| 4 | ZTS |
Zoetis Inc.
|
16,395 | $1,178,144 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,351 | $732,012 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
27,000 | $664,470 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,900 | $504,812 | |
| 8 | VTRS |
Viatris Inc
|
30,931 | $491,184 |
All Filings in BHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $410,082 | 83,181 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $403,768 | 74,772 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $210,772 | 30,327 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $345,287 | 53,533 | Shares | Defined | 2025-11-14 | |
| 2023-03-31 | $362,863 | 44,798 | Shares | Defined | 2026-04-02 | |
| 2022-12-31 | $271,095 | 43,168 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||